BUILD THERAPEUTICS ApS: Financial statements 2015
CVR: 35400060
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
BUILD THERAPEUTICS ApS (CVR 35400060) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -495 and a net result of DKK -3,927 compared with DKK -10,813 the year before. Equity in the 2015 report amounted to DKK 66,956. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -495
- Profit/Loss
- DKK -3,927
- Equity
- DKK 66,956
- Total Assets
- DKK 66,956
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 0 | -495 | -4 t. | 67 t. | - |
| 2014 | 0 | -11 t. | -11 t. | 69 t. | - |
Official annual report
How creditworthy is BUILD THERAPEUTICS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BUILD THERAPEUTICS ApS
BUILD THERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2013. The company has been dissolved on 28 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK -2,511 compared with DKK -2,511 the year before. Equity in the 2017 report amounted to DKK 64,445.